Postoperative analgesia after laparoscopic renal surgery
Conditions
Interventions
Intravenous lidocaine group:Intravenous lidocaine
Sponsors
The First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age = 18 years, ASA physical status I-III, undergoing laparoscopic renal surgery under general anesthesia (including nephrectomy and partial nephrectomy), with a clear understanding of the study and provision of written informed consent.
Exclusion criteria
Exclusion criteria: Unplanned or emergency surgery; BMI = 35 kg/m2; history of allergy to anesthetic drugs or contraindications to lidocaine; QLB contraindications (e.g., coagulation disorders, puncture site infections, sepsis); planned ICU admission after surgery; severe cardiopulmonary or cerebrovascular disease; liver or kidney dysfunction; alcohol abuse, long-term use of opioids or other analgesics; unwilling to use patient-controlled analgesia; unable to communicate or refuse to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total sufentanil consumption within 24 hours after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain scores at rest ;Pain scores on coughing;Sufentanil consumption within 24-48 hours after surgery;Rescue analgesic use within 0-48 hours after surgery;Recovery quality at 24 and 48 hours after surgery;Nausea and vomiting; | — |
Countries
China
Contacts
Public ContactPeng Ke
The First Affiliated Hospital of Soochow University
Outcome results
None listed